Skip to content

    Recently Viewed



      What you need to know about Johnson & Johnson’s 2021 second-quarter earnings

      Check out this infographic breakdown of the company’s second-quarter 2021 performance, with key highlights from its Pharmaceutical, Consumer Health and Medical Device businesses.

      Share Article
      share to
      Inset - Quarterly Earnings Ribbon
      2021 Johnson & Johnson Q2 Earnings Infographic

      This morning, Johnson & Johnson shared its second-quarter performance.

      Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 136,000 employees across the globe working every day to help change the trajectory of health for humanity.

      “Johnson & Johnson’s second-quarter results were driven by strong performance across our three business units, exceeding expectations,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “Continued market recovery favorably impacted growth comparisons as our Pharmaceutical, Medical Device and Consumer Health businesses improved their market-leading positions across many platforms. This performance underscores the resilience of our diversified business, in addition to the agility of our colleagues to meet the needs of patients and consumers around the world. We are poised to continue our pursuit of improving human health and the well-being of people around the world while delivering long-term value to all of our stakeholders well beyond 2021.”

      For more details about the company’s 2021 second-quarter results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.

      2021 Johnson & Johnson Q2 Earnings Infographic

      Johnson & Johnson’s 2021 2nd-Quarter Earnings

      Read the earnings press release, which includes full financial details for the second quarter of 2021.

      Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

      More from Johnson & Johnson

      Caring & giving
      Sam Seavey piloting an aircraft from the cockpit

      3 health advocates; 1 Johnson & Johnson program that offers empowerment and connection

      In the quest to solve the toughest health challenges, innovating therapies and finding treatments are essential—but so is supporting the patients living with these diseases. That’s exactly why Johnson & Johnson launched HealtheVoices a decade ago.
      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.